A citation-based method for searching scientific literature

I Agalliu, E Karlins, E M Kwon, L M Iwasaki, A Diamond, E A Ostrander, J L Stanford. Br J Cancer 2007
Times Cited: 70







List of co-cited articles
652 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene.
Stephen M Edwards, Zsofia Kote-Jarai, Julia Meitz, Rifat Hamoudi, Questa Hope, Peter Osin, Rachel Jackson, Christine Southgate, Rashmi Singh, Alison Falconer,[...]. Am J Hum Genet 2003
251
54


Prostate cancer progression and survival in BRCA2 mutation carriers.
Laufey Tryggvadóttir, Linda Vidarsdóttir, Tryggvi Thorgeirsson, Jon Gunnlaugur Jonasson, Elinborg Jona Olafsdóttir, Gudridur Helga Olafsdóttir, Thorunn Rafnar, Steinunn Thorlacius, Eirikur Jonsson, Jorunn Erla Eyfjord,[...]. J Natl Cancer Inst 2007
147
40

BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients.
Z Kote-Jarai, D Leongamornlert, E Saunders, M Tymrakiewicz, E Castro, N Mahmud, M Guy, S Edwards, L O'Brien, E Sawyer,[...]. Br J Cancer 2011
226
40

Germline BRCA1 mutations increase prostate cancer risk.
D Leongamornlert, N Mahmud, M Tymrakiewicz, E Saunders, T Dadaev, E Castro, C Goh, K Govindasami, M Guy, L O'Brien,[...]. Br J Cancer 2012
168
37

Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.
Elena Castro, Chee Goh, David Olmos, Ed Saunders, Daniel Leongamornlert, Malgorzata Tymrakiewicz, Nadiya Mahmud, Tokhir Dadaev, Koveela Govindasami, Michelle Guy,[...]. J Clin Oncol 2013
383
35

Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations.
Ilir Agalliu, Robert Gern, Suzanne Leanza, Robert D Burk. Clin Cancer Res 2009
82
31

Germline mutations in HOXB13 and prostate-cancer risk.
Charles M Ewing, Anna M Ray, Ethan M Lange, Kimberly A Zuhlke, Christiane M Robbins, Waibhav D Tembe, Kathleen E Wiley, Sarah D Isaacs, Dorhyun Johng, Yunfei Wang,[...]. N Engl J Med 2012
361
31

Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.
Colin C Pritchard, Joaquin Mateo, Michael F Walsh, Navonil De Sarkar, Wassim Abida, Himisha Beltran, Andrea Garofalo, Roman Gulati, Suzanne Carreira, Rosalind Eeles,[...]. N Engl J Med 2016
675
31

Cancer Incidence in BRCA1 mutation carriers.
Deborah Thompson, Douglas F Easton. J Natl Cancer Inst 2002
714
30

BRCA mutations and risk of prostate cancer in Ashkenazi Jews.
Tomas Kirchhoff, Noah D Kauff, Nandita Mitra, Kedoudja Nafa, Helen Huang, Crystal Palmer, Tony Gulati, Eve Wadsworth, Sheri Donat, Mark E Robson,[...]. Clin Cancer Res 2004
105
28

Germline BRCA mutations denote a clinicopathologic subset of prostate cancer.
David J Gallagher, Mia M Gaudet, Prodipto Pal, Tomas Kirchhoff, Lisa Balistreri, Kinjal Vora, Jasmine Bhatia, Zsofia Stadler, Samson W Fine, Victor Reuter,[...]. Clin Cancer Res 2010
171
28

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.
Joaquin Mateo, Suzanne Carreira, Shahneen Sandhu, Susana Miranda, Helen Mossop, Raquel Perez-Lopez, Daniel Nava Rodrigues, Dan Robinson, Aurelius Omlin, Nina Tunariu,[...]. N Engl J Med 2015
28

Rapid progression of prostate cancer in men with a BRCA2 mutation.
S A Narod, S Neuhausen, G Vichodez, S Armel, H T Lynch, P Ghadirian, S Cummings, O Olopade, D Stoppa-Lyonnet, F Couch,[...]. Br J Cancer 2008
97
27

Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.
C J van Asperen, R M Brohet, E J Meijers-Heijboer, N Hoogerbrugge, S Verhoef, H F A Vasen, M G E M Ausems, F H Menko, E B Gomez Garcia, J G M Klijn,[...]. J Med Genet 2005
262
24

A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology.
R M Giusti, J L Rutter, P H Duray, L S Freedman, M Konichezky, J Fisher-Fischbein, M H Greene, B Maslansky, A Fischbein, S B Gruber,[...]. J Med Genet 2003
63
25

Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype.
A Mitra, C Fisher, C S Foster, C Jameson, Y Barbachanno, J Bartlett, E Bancroft, R Doherty, Z Kote-Jarai, S Peock,[...]. Br J Cancer 2008
99
21

Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study.
Elizabeth K Bancroft, Elizabeth C Page, Elena Castro, Hans Lilja, Andrew Vickers, Daniel Sjoberg, Melissa Assel, Christopher S Foster, Gillian Mitchell, Kate Drew,[...]. Eur Urol 2014
149
21

A common variant associated with prostate cancer in European and African populations.
Laufey T Amundadottir, Patrick Sulem, Julius Gudmundsson, Agnar Helgason, Adam Baker, Bjarni A Agnarsson, Asgeir Sigurdsson, Kristrun R Benediktsdottir, Jean-Baptiste Cazier, Jesus Sainz,[...]. Nat Genet 2006
573
20

Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland.
P Lichtenstein, N V Holm, P K Verkasalo, A Iliadou, J Kaprio, M Koskenvuo, E Pukkala, A Skytthe, K Hemminki. N Engl J Med 2000
20

Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis.
S M Edwards, D G R Evans, Q Hope, A R Norman, Y Barbachano, S Bullock, Z Kote-Jarai, J Meitz, A Falconer, P Osin,[...]. Br J Cancer 2010
103
20

Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer.
Elena Castro, Chee Goh, Daniel Leongamornlert, Ed Saunders, Malgorzata Tymrakiewicz, Tokhir Dadaev, Koveela Govindasami, Michelle Guy, Steve Ellis, Debra Frost,[...]. Eur Urol 2015
172
20

Integrative clinical genomics of advanced prostate cancer.
Dan Robinson, Eliezer M Van Allen, Yi-Mi Wu, Nikolaus Schultz, Robert J Lonigro, Juan-Miguel Mosquera, Bruce Montgomery, Mary-Ellen Taplin, Colin C Pritchard, Gerhardt Attard,[...]. Cell 2015
20

The impact of a BRCA2 mutation on mortality from screen-detected prostate cancer.
M R Akbari, C J D Wallis, A Toi, J Trachtenberg, P Sun, S A Narod, R K Nam. Br J Cancer 2014
46
30

Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death.
Rong Na, S Lilly Zheng, Misop Han, Hongjie Yu, Deke Jiang, Sameep Shah, Charles M Ewing, Liti Zhang, Kristian Novakovic, Jacqueline Petkewicz,[...]. Eur Urol 2017
157
20


Multiple newly identified loci associated with prostate cancer susceptibility.
Rosalind A Eeles, Zsofia Kote-Jarai, Graham G Giles, Ali Amin Al Olama, Michelle Guy, Sarah K Jugurnauth, Shani Mulholland, Daniel A Leongamornlert, Stephen M Edwards, Jonathan Morrison,[...]. Nat Genet 2008
634
18

Multiple loci identified in a genome-wide association study of prostate cancer.
Gilles Thomas, Kevin B Jacobs, Meredith Yeager, Peter Kraft, Sholom Wacholder, Nick Orr, Kai Yu, Nilanjan Chatterjee, Robert Welch, Amy Hutchinson,[...]. Nat Genet 2008
703
18

Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes.
Julius Gudmundsson, Patrick Sulem, Valgerdur Steinthorsdottir, Jon T Bergthorsson, Gudmar Thorleifsson, Andrei Manolescu, Thorunn Rafnar, Daniel Gudbjartsson, Bjarni A Agnarsson, Adam Baker,[...]. Nat Genet 2007
546
18

Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer.
Julius Gudmundsson, Patrick Sulem, Thorunn Rafnar, Jon T Bergthorsson, Andrei Manolescu, Daniel Gudbjartsson, Bjarni A Agnarsson, Asgeir Sigurdsson, Kristrun R Benediktsdottir, Thorarinn Blondal,[...]. Nat Genet 2008
292
18

NBS1 is a prostate cancer susceptibility gene.
C Cybulski, B Górski, T Debniak, B Gliniewicz, M Mierzejewski, B Masojć, A Jakubowska, J Matyjasik, E Złowocka, A Sikorski,[...]. Cancer Res 2004
112
18

HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG).
Jianfeng Xu, Ethan M Lange, Lingyi Lu, Siqun L Zheng, Zhong Wang, Stephen N Thibodeau, Lisa A Cannon-Albright, Craig C Teerlink, Nicola J Camp, Anna M Johnson,[...]. Hum Genet 2013
123
18

A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk.
Robert Karlsson, Markus Aly, Mark Clements, Lilly Zheng, Jan Adolfsson, Jianfeng Xu, Henrik Grönberg, Fredrik Wiklund. Eur Urol 2014
83
18

Elevated risk of prostate cancer among men with Lynch syndrome.
Victoria M Raymond, Bhramar Mukherjee, Fei Wang, Shu-Chen Huang, Elena M Stoffel, Fay Kastrinos, Sapna Syngal, Kathleen A Cooney, Stephen B Gruber. J Clin Oncol 2013
102
18


Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24.
Julius Gudmundsson, Patrick Sulem, Andrei Manolescu, Laufey T Amundadottir, Daniel Gudbjartsson, Agnar Helgason, Thorunn Rafnar, Jon T Bergthorsson, Bjarni A Agnarsson, Adam Baker,[...]. Nat Genet 2007
644
17

Genome-wide association study of prostate cancer identifies a second risk locus at 8q24.
Meredith Yeager, Nick Orr, Richard B Hayes, Kevin B Jacobs, Peter Kraft, Sholom Wacholder, Mark J Minichiello, Paul Fearnhead, Kai Yu, Nilanjan Chatterjee,[...]. Nat Genet 2007
859
17

Mendelian inheritance of familial prostate cancer.
B S Carter, T H Beaty, G D Steinberg, B Childs, P C Walsh. Proc Natl Acad Sci U S A 1992
532
17

Germline mutations in the BRCA2 gene and susceptibility to hereditary prostate cancer.
Ilir Agalliu, Erika M Kwon, Daniel Zadory, Laura McIntosh, Joseph Thompson, Janet L Stanford, Elaine A Ostrander. Clin Cancer Res 2007
31
35


Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men.
K L Nastiuk, M Mansukhani, M B Terry, P Kularatne, M A Rubin, J Melamed, M D Gammon, M Ittmann, J J Krolewski. Prostate 1999
50
22

Loss of heterozygosity at the BRCA2 locus detected by multiplex ligation-dependent probe amplification is common in prostate cancers from men with a germline BRCA2 mutation.
Amber J Willems, Sarah-Jane Dawson, Hema Samaratunga, Alessandro De Luca, Yoland C Antill, John L Hopper, Heather J Thorne. Clin Cancer Res 2008
32
34

Decreased prostate cancer-specific survival of men with BRCA2 mutations from multiple breast cancer families.
Heather Thorne, Amber J Willems, Eveline Niedermayr, Ivan M Y Hoh, Jason Li, David Clouston, Gillian Mitchell, Stephen Fox, John L Hopper, Damien Bolton. Cancer Prev Res (Phila) 2011
76
15

Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian.
Jacqueline Mersch, Michelle A Jackson, Minjeong Park, Denise Nebgen, Susan K Peterson, Claire Singletary, Banu K Arun, Jennifer K Litton. Cancer 2015
261
15

Risk of prostate cancer in Lynch syndrome: a systematic review and meta-analysis.
Shae Ryan, Mark A Jenkins, Aung Ko Win. Cancer Epidemiol Biomarkers Prev 2014
70
15


Cumulative association of five genetic variants with prostate cancer.
S Lilly Zheng, Jielin Sun, Fredrik Wiklund, Shelly Smith, Pär Stattin, Ge Li, Hans-Olov Adami, Fang-Chi Hsu, Yi Zhu, Katarina Bälter,[...]. N Engl J Med 2008
471
14

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
J P Struewing, P Hartge, S Wacholder, S M Baker, M Berlin, M McAdams, M M Timmerman, L C Brody, M A Tucker. N Engl J Med 1997
14

Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.
Rosalind A Eeles, Zsofia Kote-Jarai, Ali Amin Al Olama, Graham G Giles, Michelle Guy, Gianluca Severi, Kenneth Muir, John L Hopper, Brian E Henderson, Christopher A Haiman,[...]. Nat Genet 2009
335
14

Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21.
Christopher A Haiman, Gary K Chen, William J Blot, Sara S Strom, Sonja I Berndt, Rick A Kittles, Benjamin A Rybicki, William B Isaacs, Sue A Ingles, Janet L Stanford,[...]. Nat Genet 2011
158
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.